Capsiate administration results in an uncoupling protein-3 downregulation, an enhanced muscle oxidative capacity and a decreased abdominal fat content in vivo

International Journal of Obesity

Volumn 33, Issue 12, 2009, Pages 1348-1355

  Faraut, B ^a   Giannesini, B ^a   Matarazzo, V ^b   Le Fur, Y ^a   Rougon, G ^b   Cozzone, P J ^a   Bendahan, D ^a  

^a University of Aix Marseille   (France)

^b CNRS   (France)

Author keywords

Capsiate; Capsinoids; Energy metabolism; Skeletal muscle; Uncoupling proteins

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; SYNAPSIN II; CAPSAICIN; CAPSIATE; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; UNCOUPLING PROTEIN;

ABDOMINAL FAT; AEROBIC EXERCISE; ALKALOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; GASTROCNEMIUS MUSCLE; GENE CONTROL; GENE EXPRESSION; GLYCOLYSIS; MUSCLE EXCITATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WEIGHT GAIN; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; MUSCLE MITOCHONDRION; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ABDOMINAL FAT; ANIMALS; CAPSAICIN; DOWN-REGULATION; ENERGY METABOLISM; FEMALE; ION CHANNELS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OXIDATION-REDUCTION; RATS; UNCOUPLING AGENTS;

ANIMALIA; RATTUS;

EID: 72049083472     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.182     Document Type: Article

References (22)

1. Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 1997; 235: 79-82.
2. Schrauwen P, Hesselink M. Uncoupling protein 3 and physical activity: the role of uncoupling protein 3 in energy metabolism revisited. Proc Nutr Soc 2003; 62: 635-643.
3. Brand MD, Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2005; 2: 85-93.
4. Schrauwen P, Hoeks J, Schaart E, Kornips B, Binas B, Van De Vusse GJ et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 2003; 17: 2272-2274.
5. Faraut B, Giannesini B, Matarazzo V, Marqueste T, Dalamasso C, Rougon G et al. Downregulation of uncoupling protein-3 is linked to changes in muscle mitochondrial energy metabolism in vivo as a result of capsiate administration. Am J Physiol Endocrinol Metab 2007; 292: E1474-E1482.
6. Ohnuki K, Niwa S, Maeda S, Inoue N, Yazawa S, Fushiki T et al. CH-19 sweet, a non-pungent cultivar of red pepper, increased body temperature and oxygen consumption in humans. Biosci Biotechnol Biochem 2001; 65: 2033-2036. (Pubitemid 33667821)
7. 31P-MR spectroscopy. Magn Reson Med 2005; 54: 1058-1064.
8. Kobata K, Kawaguchi M, Watanabe T. Enzymatic synthesis of a capsinoid by the acylation of vanillyl alcohol with fatty acid derivatives catalyzed by lipases. Biosci Biotechnol Biochem 2002; 66: 319-327.
9. Ohnuki K, Haramizu S, Oki K, Watanabe T, Yazawa S, Fushiki T. Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice. Biosci Biotechnol Biochem 2001; 65: 2735-2740.
10. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43.
11. 31P NMR. Magn Reson Med 1984; 1: 307-315.
12. Masuda Y, Haramizu S, Oki K, Ohnuki K, Yazawa S, Kawada T et al. Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog. J Appl Physiol 2003; 95: 2408-2415.
13. Jensen MD. Fate of fatty acids at rest and during exercise: regulatory mechanisms. Acta Physiol Scand 2003; 178: 385-390.
14. Gong DW, Monemdjou S, Gavrilova O, Leon LR, Marcus-Samuels B, Chou CJ et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000; 275: 16251-16257.
15. Cline GW, Vidal-Puig AJ, Dufour S, Cadman KS, Lowell BB, Shulman GI et al. In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem 2001; 276: 20240-20244.
16. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, Ido Y et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000; 275: 16258-16266.
17. Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000; 406: 415-418.
18. Costford SR, Chaudhry SN, Salkhordeh M, Harper ME. Effects of the presence, absence, and overexpression of uncoupling protein-3 on adiposity and fuel metabolism in congenic mice. Am J Physiol Endocrinol Metab 2006; 290: E1304-E1312.
19. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
20. Ross R, Leger L, Guardo R, De Guise J, Pike BG. Adipose tissue volume measured by magnetic resonance imaging and computerized tomography in rats. J Appl Physiol 1991; 70: 2164-2172.
21. Mingrone G, Rosa G, Greco AV, Manco M, Vega N, Hesselink MK et al. Decreased uncoupling protein expression and intramyocytic triglyceride depletion in formerly obese subjects. Obes Res 2003; 11: 632-640.
22. Schrauwen P, Schaart G, Saris WH, Slieker LJ, Glatz JF, Vidal H et al. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in type II diabetic subjects. Diabetologia 2000; 43: 1408-1416